Altogether, these results support the use of more in depth standardized immunophenotypic studies that include the analysis of CM/TM TCD4+ and TCD8+ cells and CD141+ myDC in blood, in patients that present with thymoma and clinical suspicion of immunodeficiency, even when serum Ig levels are normal. This evidence concerns the gene THBD and thymoma.